K3 BUSINESS TECHNOLOGY GROUP PLC

Director's Dealing • Jun 17, 2025

National Storage Mechanism | Additional information

RNS Number : 2173N

K3 Business Technology Group PLC

17 June 2025

K3 Business Technology Group plc

("K3", "Company" or "Group")

PDMR Announcement

K3 Business Technology Group plc ("K3" or the "Company"), which provides business‐critical software solutions focused on fashion and apparel brands, has received notification from Mr Oliver Scott, Chair of K3, of the following Kestrel intra-client transfers in the ordinary shares of 25p each in K3 ("Shares") on 13 June 2025 at a price of 68.99p per share. Mr Scott is deemed to have had an interest in these transactions as described below.

Mr. Scott is a partner of, and holds a beneficial interest in, Kestrel Partners LLP ("Kestrel").

Kestrel transferred 13,274,493 Shares in K3 held by certain Kestrel clients to certain other Kestrel clients. As part of this transaction, Kestrel Opportunities ("KOF") transferred out its entire holding of 9,031,682 Shares. Mr Scott is a shareholder in KOF and was therefore deemed to have had an indirect beneficial interest in KOF's entire legal holding in K3. Following this transfer Mr Scott will no longer have any indirect beneficial interest in K3 via KOF. However, Mr Scott now has a direct beneficial interest in one of the Kestrel clients that is receiving 355,360 Shares in K3 as a result of these transfers.

Following these transfers, on a combined basis, Kestrel's interest in K3 remains unchanged and it continues to control voting rights over 13,587,284 Shares, representing 29.58% of the Company's issued share capital.

In addition to this, Mr Scott continues to hold an indirect beneficial interest via a family trust in 3,585 K3 Shares representing 0.01% of the Company's issued share capital.

Following the transfers described above, Kestrel's voting rights over the Shares of the Company are held through the following nominees:

Holding type	Nominee	No. of shares	% of issued share capital
Indirect	APEX Group Nominees	12,919,133	28.13%
Direct	APEX Group Nominees	355,360	0.77%
Indirect	JIM Nominees Limited	316,376	0.69%

Further details in respect of the transfer are provided below, in accordance with the EU Market Abuse Regulation (No 596/2014).

For further information contact:

K3 Business Technology Group plc	+44 (0) 161 876 4498
Eric Dodd, CEO
Cavendish Capital Markets Limited	+44 (0) 207 220 0500
Nominated Adviser and Broker
Julian Blunt/Callum Davidson (Corporate Finance)
Sunila de Silva/Harriet Ward (Corporate Broking)
KTZ Communications	+44 (0) 20 3178 6378
Katie Tzouliadis/Robert Morton

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kestrel Partners LLP ('Kestrel')

2

Reason for the notification

a)

Position/status

PCA - Oliver Rupert Andrew Scott (Chair of K3 Business Technology Group plc and Partner in Kestrel)

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

K3 Business Technology Group plc

b)

LEI

213800QOJ9OF2AV81748

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

25p Ordinary Shares

ISIN: GB00B00P6061

b)

Nature of the transaction

Intra-client transfers.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.6899	13,274,493 shares

d)

Aggregated information

As above.

e)

Date of the transaction

13 June 2025

f)

Place of the transaction

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBBGDLCDBDGUR